Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07391423 · ClinicalTrials.gov registry record · NA

Assessing Psoriasis Treatment Outcomes

A NA study, sponsored by Wake Forest University Health Sciences.

Not yet
Registry status
NA
Development phase
15
Enrollment target

NCT07391423 is a NA study that has not yet begun recruiting, run by Wake Forest University Health Sciences. The registered enrollment target is 15 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07391423, a NA study, has not yet begun recruiting, sponsored by Wake Forest University Health Sciences.

NOT YET RECRUITING
Registry status
NA
Development phase
15 participants
Enrollment target

Study Summary

To assess the feasibility of AIGPP video interactions with psoriasis patients. To explore patient attitudes, trust, and comfort levels concerning AIGPP interactions in a healthcare setting, and to understand their influence on the patient-physician dynamic. To evaluate medication adherence over a 4-week period in patients with psoriasis randomized to weekly AI-generated automated physician providers (AIGPP) video interactions, weekly human video calls, or standard care (single follow up visit after 4 weeks). Adherence rates will be evaluated via a cap designed to record adherence attached to the study medication container.

Interventions

  • OTHER Standard of Care
  • BEHAVIORAL Artificial intelligence
  • BEHAVIORAL Human

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2026-07
Est. Completion 2029-03
Phase NA

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT07391423

The ClinicalTrials.gov registry entry for NCT07391423 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Standard of Care is the first listed.

NCT07391423 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07391423 about?

NCT07391423 is a clinical study titled "Assessing Psoriasis Treatment Outcomes". To assess the feasibility of AIGPP video interactions with psoriasis patients. To explore patient attitudes, trust, and comfort levels concerning AIGPP interactions in a healthcare setting, and to understand their influence on the patient-physician dynamic. To evaluate medication adherence over a 4-...

What is the current status of trial NCT07391423?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2026-07. Estimated completion is 2029-03.

What interventions are being tested in trial NCT07391423?

The interventions under investigation include: Standard of Care (OTHER), Artificial intelligence (BEHAVIORAL), Human (BEHAVIORAL).

Who is sponsoring clinical trial NCT07391423?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.